Header Logo

AZIZ SHAIBANI

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6624 Fannin, Suite 1670
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aggarwal R, Lundberg IE, Song YW, Shaibani A, Werth VP, Maldonado MA, Aggarwal R, Lundberg IE, Song YW, Shaibani A, Werth VP, Maldonado MA. Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. Arthritis Rheumatol. 2025 Jun; 77(6):765-776. PMID: 39609094; PMCID: PMC12123255.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    2. Benedetti F, Thoen W, Shaibani A, Arduino C. Placebo nonresponders: An experimental investigation on their unreliability over time. J Pain. 2025 Mar; 28:104777. PMID: 39805378.
      Citations:    Fields:    Translation:Humans
    3. Frisaldi E, Ferrero B, Di Liberto A, Barbiani D, Camerone EM, Piedimonte A, Vollert J, Cavallo R, Zibetti M, Lopiano L, Shaibani A, Benedetti F. The impact of patients' pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study. Muscle Nerve. 2024 Sep; 70(3):413-419. PMID: 38940302.
      Citations:    
    4. Benedetti F, Arduino C, Shaibani A, Thoen W. Creating Placebo Nonresponders in the Lab. J Pain. 2024 04; 25(4):962-973. PMID: 37907113.
      Citations:    
    5. Michelson D, Chin WW, Dworkin RH, Freeman R, Herrmann DN, Mazitschek R, Pop-Busui R, Shaibani A, Vornov J, Jones M, Jarpe M, Hader B, Viera T, Hylan M, Kachmar T, Jones S. A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy. Pain Rep. 2023 Dec; 8(6):e1114. PMID: 37899940; PMCID: PMC10611336.
      Citations:    
    6. Frisaldi E, Shaibani A, Benedetti F, Pagnini F. Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review. BMJ Open. 2023 10 17; 13(10):e077243. PMID: 37848293; PMCID: PMC10582987.
      Citations:    
    7. Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, J?rgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM, Arimoclomol in IBM Investigator Team of the Neuromuscular Study Group. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911. PMID: 37739573.
      Citations:    Fields:    Translation:HumansAnimals
    8. Frisaldi E, Vollert J, Al Sultani H, Benedetti F, Shaibani A. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis. Pain. 2024 Jan 01; 165(1):29-43. PMID: 37530658.
      Citations:    
    9. Benedetti F, Shaibani A, Arduino C, Thoen W. Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone. Pain. 2023 05 01; 164(5):984-990. PMID: 36165878.
      Citations:    
    10. Al Sultani H, Hafeez K, Shaibani A. Diagnostic Outcome of Genetic Testing for Neuromuscular Disorders in a Tertiary Center. J Clin Neuromuscul Dis. 2022 Sep 01; 24(1):1-6. PMID: 36005468.
      Citations:    
    11. Hafeez K, Kushlaf H, Al-Sultani H, Joseph AC, Zaeem Z, Siddiqi Z, Laboy S, Pulley M, Habib AA, Robbins NM, Zadeh S, Hafeez MU, Hussain Y, Melendez-Zaidi A, Kassardjian C, Johnson K, Leonhard H, Biliciler S, Patino Murillas JE, Shaibani AI. Patient preference for virtual versus in-person visits in neuromuscular clinical practice. Muscle Nerve. 2022 08; 66(2):142-147. PMID: 35596667; PMCID: PMC9540760.
      Citations:    Fields:    Translation:Humans
    12. Kim Y, Li X, Huang Y, Kim M, Shaibani A, Sheikh K, Zhang GQ, Nguyen TP. COVID-19 Outcomes in Myasthenia Gravis Patients: Analysis From Electronic Health Records in the United States. Front Neurol. 2022; 13:802559. PMID: 35418937; PMCID: PMC8996116.
      Citations: 1     
    13. Frisaldi E, Shaibani A, Trucco M, Milano E, Benedetti F. What is the role of placebo in neurotherapeutics? Expert Rev Neurother. 2022 Jan; 22(1):15-25. PMID: 34845956.
      Citations:    
    14. Wencel M, Shaibani A, Goyal NA, Dimachkie MM, Trivedi J, Johnson NE, Gutmann L, Wicklund MP, Bandyopadhay S, Genge AL, Freimer ML, Goyal N, Pestronk A, Florence J, Karam C, Ralph JW, Rasheed Z, Hays M, Hopkins S, Mozaffar T. Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices: The IPaNeMA Study. Neurol Genet. 2021 Dec; 7(6):e623. PMID: 36299500; PMCID: PMC9595038.
      Citations: 2     
    15. Benedetti F, Frisaldi E, Shaibani A. Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad. Annu Rev Pharmacol Toxicol. 2022 01 06; 62:323-340. PMID: 34460317.
      Citations:    
    16. Benedetti F, Amanzio M, Giovannelli F, Craigs-Brackhahn K, Shaibani A. Hypothalamic-Pituitary-Adrenal Activity in Adverse Events Reporting After Placebo Administration. Clin Pharmacol Ther. 2021 11; 110(5):1349-1357. PMID: 34365636.
      Citations:    
    17. Shaibani A, Khan S, Shinawi M. Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia. Neurol Genet. 2021 Aug; 7(4):e612. PMID: 34291158; PMCID: PMC8290902.
      Citations:    
    18. Sung A, Moretti P, Shaibani A. Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene. Neurol Genet. 2021 Aug; 7(4):e599. PMID: 34169149; PMCID: PMC8220962.
      Citations:    
    19. Lopez MA, Bontiff S, Adeyeye M, Shaibani AI, Alexander MS, Wynd S, Boriek AM. Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C230-C246. PMID: 33979214; PMCID: PMC8424675.
      Citations: 1     Fields:    Translation:AnimalsCells
    20. RESILIENT Study Extension Group, Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tank? LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Zhang Auberson L. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607. PMID: 33597289; PMCID: PMC8032371.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    21. Kessler JA, Shaibani A, Sang CN, Christiansen M, Kudrow D, Vinik A, Shin N, VM202 study group. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci. 2021 05; 14(3):1176-1184. PMID: 33465273; PMCID: PMC8212761.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    22. Frisaldi E, Shaibani A, Benedetti F. Understanding the mechanisms of placebo and nocebo effects. Swiss Med Wkly. 2020 Aug 24; 150:w20340. PMID: 32920787.
      Citations:    
    23. Shaibani A. Preface. Neurol Clin. 2020 08; 38(3):xv-xvi. PMID: 32703479.
      Citations:    Fields:    
    24. MGTX study group, Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Str?bel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI. Minimal manifestation status and prednisone withdrawal in the MGTX trial. Neurology. 2020 08 11; 95(6):e755-e766. PMID: 32611638; PMCID: PMC7455358.
      Citations: 2     Fields:    Translation:HumansAnimals
    25. Shaibani A, Al Sultani H. Refractory Chronic Immune-mediated Demyelinating Polyneuropathy. Neurol Clin. 2020 08; 38(3):591-605. PMID: 32703471.
      Citations:    Fields:    Translation:Humans
    26. Benedetti F, Frisaldi E, Barbiani D, Camerone E, Shaibani A. Nocebo and the contribution of psychosocial factors to the generation of pain. J Neural Transm (Vienna). 2020 04; 127(4):687-696. PMID: 31758266.
      Citations:    
    27. Hanna MG, Badrising UA, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group, Benveniste O, Oskarsson B, Mirabella M. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844. PMID: 31397289.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    28. Frisaldi E, Shaibani A, Vollert J, Ferrero B, Carrino R, Ibraheem HD, Vase L, Benedetti F. The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: A meta-analysis. Muscle Nerve. 2019 06; 59(6):671-678. PMID: 30883809.
      Citations:    
    29. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, MGTX Study Group, Str?bel P, Dias-Tosta E, Waddington-Cruz M. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol. 2019 03; 18(3):259-268. PMID: 30692052; PMCID: PMC6774753.
      Citations:    
    30. Frisaldi E, Shaibani A, Benedetti F. Placebo responders and nonresponders: what's new? Pain Manag. 2018 11 01; 8(6):405-408. PMID: 30873895.
      Citations:    
    31. Komal FNU, Moretti PM, Shaibani AI. Deoxyguanosine kinase mutation producing juvenile-onset mitochondrial myopathy. Neurol Genet. 2018 Oct; 4(5):e269. PMID: 30283818; PMCID: PMC6167180.
      Citations:    
    32. Sung AR, Moretti P, Shaibani A. Case of late-onset Sandhoff disease due to a novel mutation in the HEXB gene. Neurol Genet. 2018 Aug; 4(4):e260. PMID: 30065954; PMCID: PMC6066361.
      Citations: 4     
    33. Benedetti F, Frisaldi E, Shaibani A. Placebo effects: the need for a new perspective and conceptualization. Expert Rev Clin Pharmacol. 2018 Jun; 11(6):543-544. PMID: 29745259.
      Citations:    
    34. Benedetti F, Shaibani A. Nocebo effects: more investigation is needed. Expert Opin Drug Saf. 2018 Jun; 17(6):541-543. PMID: 29768057.
      Citations:    
    35. Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, Russell JW, Shaibani A, Mauermann ML, Hehir MK, Kolb N, Guptill J, Hobson-Webb L, Gable K, Raja S, Silvestri N, Wolfe GI, Smith AG, Malik R, Traub R, Joshi A, Elliott MP, Jones S, Burns TM. Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology. 2018 06 05; 90(23):e2034-e2041. PMID: 29728528; PMCID: PMC5993178.
      Citations: 1     Fields:    Translation:Humans
    36. Bainbridge J, De Backer M, Eckhardt K, Tennigkeit F, Bongardt S, Sen D, Werhahn KJ, Shaibani A, Faught E. Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain. Epilepsia Open. 2017 12; 2(4):415-423. PMID: 29588972; PMCID: PMC5862116.
      Citations: 2     Fields:    
    37. Shaibani A, Frisaldi E, Benedetti F. Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders. Muscle Nerve. 2017 09; 56(3):358-367. PMID: 28249354.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    38. Frisaldi E, Shaibani A, Benedetti F. Why We should Assess Patients' Expectations in Clinical Trials. Pain Ther. 2017 Jun; 6(1):107-110. PMID: 28477082; PMCID: PMC5447548.
      Citations:    
    39. Khalid U, Massumi A, Shaibani A. Swallowing-induced Supraventricular Tachyarrhythmia. Rev Cardiovasc Med. 2017; 18(1):53-58. PMID: 28509894.
      Citations: 3     Fields:    Translation:Humans
    40. MGTX Study Group, Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str?bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 08 11; 375(6):511-22. PMID: 27509100; PMCID: PMC5189669.
      Citations: 180     Fields:    Translation:Humans
    41. Gang Q, Bettencourt C, Machado PM, Brady S, Holton JL, Pittman AM, Hughes D, Healy E, Parton M, Hilton-Jones D, Shieh PB, Needham M, Liang C, Zanoteli E, de Camargo LV, De Paepe B, De Bleecker J, Shaibani A, Ripolone M, Violano R, Moggio M, Barohn RJ, Dimachkie MM, Mora M, Mantegazza R, Zanotti S, Singleton AB, Hanna MG, Houlden H, Muscle Study Group and The International IBM Genetics Consortium, Bettencourt C, Zanoteli E, de Camargo LV. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol Aging. 2016 11; 47:218.e1-218.e9. PMID: 27594680; PMCID: PMC5082791.
      Citations:    
    42. Shaibani A. Distal Myopathies: Case Studies. Neurol Clin. 2016 Aug; 34(3):547-64. PMID: 27445241.
      Citations:    Fields:    Translation:Humans
    43. Verla T, Thomas JG, Thomazy V, Fuller GN, Shaibani A, Omeis I. Fulminant spinal cord compression caused by postradiation inflammatory pseudotumor with rapid response to steroids: case report. J Neurosurg Spine. 2016 Nov; 25(5):660-664. PMID: 27231814.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    44. Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM, Hehir MK, Hobson-Webb LD, Howard JF, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine. Muscle Nerve. 2016 Feb; 53(2):165-8. PMID: 26662952.
      Citations: 2     Fields:    Translation:Humans
    45. Polydefkis M, Arezzo J, Nash M, Bril V, Shaibani A, Gordon RJ, Bradshaw KL, Junor RW, Ranirestat Study Group. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015 Dec; 20(4):363-71. PMID: 26313450.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    46. Kessler JA, Smith AG, Cha BS, Choi SH, Wymer J, Shaibani A, Ajroud-Driss S, Vinik A, VM202 DPN-II Study Group. Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann Clin Transl Neurol. 2015 May; 2(5):465-78. PMID: 26000320; PMCID: PMC4435702.
      Citations: 21     Fields:    
    47. Gang Q, Bettencourt C, Machado PM, Fox Z, Brady S, Healy E, Parton M, Holton JL, Hilton-Jones D, Shieh PB, Zanoteli E, De Paepe B, De Bleecker J, Shaibani A, Ripolone M, Violano R, Moggio M, Barohn RJ, Dimachkie MM, Mora M, Mantegazza R, Zanotti S, Hanna MG, Houlden H, Muscle Study Group and the International IBM Genetics Consortium(#), Zanoteli E. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiol Aging. 2015 Apr; 36(4):1766.e1-1766.e3. PMID: 25670332; PMCID: PMC4378665.
      Citations:    
    48. Shaibani A, Wong LJ, Wei Zhang V, Lewis RA, Shinawi M. Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the FLVCR1 gene. Int J Neurosci. 2015 Jan; 125(1):43-9. PMID: 24628582.
      Citations: 9     Fields:    Translation:Humans
    49. Bekheirnia MR, Zhang W, Eble T, Willis A, Shaibani A, Wong LJ, Scaglia F, Dhar SU. POLG mutation in a patient with cataracts, early-onset distal muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic aciduria. Gene. 2012 May 10; 499(1):209-12. PMID: 22405928.
      Citations: 8     Fields:    Translation:Humans
    50. Shaibani AI, Pope LE, Thisted R, Hepner A. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study. Pain Med. 2012 Feb; 13(2):243-54. PMID: 22314263.
      Citations: 10     Fields:    Translation:Humans
    51. Mendez-Figueroa H, Shchelochkov OA, Shaibani A, Aagaard-Tillery K, Shinawi MS. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy. J Perinatol. 2010 Aug; 30(8):558-62. PMID: 20668464.
      Citations: 5     Fields:    Translation:Humans
    52. Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Wong LJ, Shinawi M. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol. 2009 Aug; 66(8):1028-32. PMID: 19667227; PMCID: PMC2747647.
      Citations: 34     Fields:    Translation:Humans
    53. Shaibani A, Fares S, Selam JL, Arslanian A, Simpson J, Sen D, Bongardt S. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain. 2009 Aug; 10(8):818-28. PMID: 19409861.
      Citations: 29     Fields:    Translation:Humans
    54. Shchelochkov O, Wong LJ, Shaibani A, Shinawi M. Atypical presentation of VLCAD deficiency associated with a novel ACADVL splicing mutation. Muscle Nerve. 2009 Mar; 39(3):374-82. PMID: 19208414.
      Citations: 4     Fields:    Translation:Humans
    55. Shaibani A, Biton V, Rauck R, Koch B, Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain. 2009 May; 13(5):458-63. PMID: 18619874.
      Citations:    
    56. Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb; 23(2):150-8. PMID: 17237664.
      Citations: 28     Fields:    Translation:Humans
    57. Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006 Jun; 113(6):395-404. PMID: 16674606.
      Citations:    
    58. Shaibani A, Gooch C, Harati Y. Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP). Muscle Nerve. 1997 Jul; 20(7):881-3. PMID: 9179161.
      Citations: 3     Fields:    Translation:Humans
    SHAIBANI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (222)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _